Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models
Carla P. Gomes is a Professor of Computer Science at Cornell University with joint appointments in the Department of Computer Science and the Dyson School of Applied Economics and Management. She holds a PhD in computer science from the University of Edinburgh and an M.Sc. in applied mathematics from the University of Lisbon. Her research focuses on artificial intelligence, constraint reasoning, optimization, and computational sustainability. As Director of the Institute for Computational Sustainability (ICS) and co-director of the Cornell University AI for Science Institute, she leads efforts to integrate AI with sustainability challenges. Her research themes include the integration of constraint reasoning, machine learning, and operations research to solve large-scale problems. She pioneered the field of Computational Sustainability, addressing environmental, economic, and societal challenges through AI. Gomes directed two NSF Expeditions in Computing awards and established CompSustNet, a large-scale sustainability research network. Key awards include the 2021 ACM–AAAI Allen Newell Award, AAAI Feigenbaum Prize, and fellowships from AAAI, ACM, and AAAS. Her work spans over 200 publications, with contributions to AI, sustainability, and materials discovery. She advises numerous PhD students and oversees postdocs in AI, sustainability, and interdisciplinary projects. Gomes' lab focuses on AI for scientific discovery, including autonomous materials synthesis and crystal-structure phase mapping. She collaborates with institutions like JCAP and the Materials Project, advancing AI-driven solutions for energy and environmental challenges. Current projects include Schmidt AI in Science postdoc initiatives and AI-driven materials discovery platforms like DRNets and SARA.
Mohammad Peydayesh is a Lecturer and Senior Researcher at the Department of Health Sciences and Technology , ETH Zürich. He works in the Food and Soft Material Laboratory , focusing on sustainable materials derived from food waste and agri-food byproducts. PhD in Chemical Engineering (2018, Iran University of Science and Technology) Postdoctoral Fellow at ETH Zürich under Prof. Dr. Mezzenga Senior Assistant at ETH Zürich since 2021 His research spans soft matter , self-assembly phenomena , and amyloid fibril applications in: Environmental engineering (water purification, heavy metal removal) CO2 conversion and storage Smart packaging and bioplastics development Biorefinery concepts and circular economy Nanomaterials for waste valorization Recent publications highlight trends in amyloid-based hybrid materials for: Metal recovery from e-waste and contaminated water CO2 capture and conversion Bioplastic production from agricultural waste Antiviral and detoxification applications Water desalination and purification Photonic and catalytic materials He contributes to the Laboratory of Food & Soft Materials , advancing sustainable solutions through interdisciplinary material science.
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Yevgeny Brudno, PhD, is an Associate Professor at the Eshelman School of Pharmacy (UNC-Chapel Hill) with a joint appointment in Biomedical Engineering (UNC and NC State University). He is a member of the UNC Lineberger Comprehensive Cancer Center and leads the Brudno Lab, which specializes in drug delivery and biomaterials for cancer immunotherapy, particularly CAR T cell therapy. Research Focus: Development of implantable biotechnologies for in vivo CAR-T cell production, biomaterials for therapeutic delivery, and click chemistry-based drug targeting. Education: PhD (unspecified institution). The lab’s research bridges chemical and biomaterials science with clinical needs, emphasizing on-demand drug release , solid tumor targeting , and autoimmune disease treatments . Recent work includes bioinstructive scaffolds and tissue-reactive drug depots , leveraging click chemistry and nanomedicine . His scientific contributions are highlighted by 15 publications (2009–2025) in fields like biotechnology, cancer immunotherapy, and epigenetics. Notable awards include the NCI MERIT Award , University Faculty Scholar (NC State), and Outstanding Teacher Award (NC State). Advising: Mentored 13 PhD and Master’s students, including Sharda Pandit (2023), Chris Moody (2021), and Emily Joe (2024). Lab announcements highlight student achievements like NSF and NIH fellowships. The Brudno Lab collaborates with UNC Lineberger and NC State, focusing on streamlining therapy production , enhancing efficacy in solid tumors , and autoimmune disease applications , supported by grants from NCI and CMI.
Lisa Westerberg is a Professor of Experimental Immunology at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Her research focuses on understanding how compromised immune systems lead to immunodeficiency, autoimmunity, and hematological cancers, particularly studying the role of actin regulators in immune cell function. She leads the 'Immunodeficiency Diseases – Lisa Westerberg Group' and collaborates internationally with institutions like Harvard Medical School and the University College London. Education: PhD in Cell and Molecular Biology from Karolinska Institutet (2003), postdoc at Harvard Medical School (2009). Affiliations: Department of Microbiology, Tumor and Cell Biology; WASPSTINGS network (STINT-funded); Swedish Society for Immunology (Treasurer). Research Interests: Immunodeficiency diseases, actin cytoskeleton dynamics in immune cells, cancer immunology, and space immunology. Her lab investigates how genetic mutations in actin regulators affect immune cell communication, migration, and genomic stability. Recent projects include studying immune system adaptation in microgravity and developing therapies targeting actin regulators in cancer. Articles Trends: Recent work highlights immune cell adaptations in space environments, therapeutic modulation of actin pathways, and clonal evolution in lymphomas. Over 15 articles since 2020 explore mechanisms linking immune dysfunction to cancer and immunodeficiency. Awards: Ragnar Söderberg Fellowship, ERC Starting Grant (2019), Wallenberg Academy Fellow. Funding: Swedish Research Council, Knut och Alice Wallenberg Foundation, EU grants. Advising & Grants: Supervised over 40 students (PhD, Master’s, undergrad) since 2010. Active in training programs like the Amgen Scholars initiative. Collaborates with global teams on projects funded by VR, NIH, and international partnerships. Labs/Teams: Leads the core Immunodeficiency Diseases Group and collaborates with the Dosenovic Lab (focusing on B cell vaccine development). The group uses CRISPR, high-resolution microscopy, and single-cell sequencing to study immune mechanisms.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Jeff Schorey is the George B. Craig Jr. Professor and a full Professor in the Department of Biological Sciences at the University of Notre Dame, where he has been a faculty member since 2004. He currently serves as Director of the Integrated Biomedical Sciences (IBMS) graduate program and previously held leadership roles including Chair of the Institutional Animal Care and Use Committee (IACUC) and Associate Director of the Eck Institute for Global Health. His research focuses on the pathobiology of mycobacterial diseases, particularly Mycobacterium tuberculosis and M. avium . His work investigates the molecular interactions between mycobacteria and host macrophages, with a special emphasis on the role of exosomes in immune modulation, diagnostics, and vaccine development. He also explores novel antibiotic development in collaboration with chemists at Notre Dame and global partners. His recent publications reveal a strong trend in extracellular vesicle biology, host-pathogen signaling, and translational applications in TB diagnostics and treatment. The articles span immunology, microbiology, and molecular biology, with recurring themes in exosome function, RNA sensing, and antimicrobial development. George B. Craig Jr. Collegiate Professor Dr. Schorey has advised graduate students and leads an active research lab focused on mycobacterial pathogenesis. His work is supported by collaborations across disciplines and institutions, particularly in drug development and clinical translation. He has contributed significantly to understanding how exosomes can serve as both biomarkers and therapeutic tools. His lab employs cellular immunology, animal models, and clinical sample analysis to study mycobacterial infections. He leads the IBMS program, shaping graduate education in biomedical sciences at Notre Dame.
Sean Howe is an Assistant Professor in the Department of Mathematics at the University of Utah, where he has been employed since July 2019. His research is supported by NSF grants DMS-2201112 and DMS-2501816. In the academic year 2023-2024, he was a Friends of the Institute for Advanced Study Member at the special year on p-adic arithmetic geometry at the Institute for Advanced Study. Dr. Howe received his PhD from the University of Chicago in 2017 under the supervision of Matt Emerton. Prior to his position at Utah, he was an NSF Postdoctoral Scholar at Stanford University from September 2017 to June 2019. He earned a joint master's degree from Leiden University and Universite Paris-Sud 11 through the ALGANT program in 2012 and completed his undergraduate studies at the University of Arizona. Dr. Howe's research spans arithmetic and algebraic geometry, representation theory, and number theory, with a particular focus on p-adic aspects. His work often explores the connections between geometry and number theory through the lens of p-adic methods, including p-adic Hodge theory, perfectoid spaces, and the Langlands program. He has made significant contributions to understanding cohomological structures in mixed characteristic settings, the geometry of moduli spaces, and the statistical properties of L-functions. His extensive publication record demonstrates a strong trajectory in advancing p-adic geometry and its applications. Recent work shows increasing focus on cohomological smoothness in mixed characteristic, p-adic periods, and the interplay between random matrix theory and arithmetic statistics. His research often bridges abstract theoretical frameworks with concrete computational approaches. NSF Postdoctoral Scholar NSF grants DMS-2201112 and DMS-2501816 Dr. Howe is an active mentor, currently advising five PhD students: Minhua Cheng, Madison Delmoe, Shea Engle, Abhay Goel, and Suo Jun Tan. He has successfully graduated two PhD students: Matthew Bertucci (2025) and Hanlin Cai (2024). He also regularly mentors undergraduate researchers, with notable projects including Emil Geisler's work on stable multiplicities in configuration space cohomology and Daniel Koizumi's software for computing braid monodromy of cubic surfaces. His teaching portfolio includes advanced courses in algebraic topology, number theory, and algebra, reflecting his broad expertise across pure mathematics. He has taught courses such as Math 6950 (Topics in Algebraic Topology), Math 4400 (Introduction to Number Theory), and Math 6320 (Modern Algebra II).
Janusz Bujnicki is a Professor and head of the Laboratory of Bioinformatics and Protein Engineering at the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), Poland. He holds concurrent roles in science policy advisory bodies, including the European Commission's Group of Chief Scientific Advisors (2015-2020, then expert) and the Polish Academy of Sciences’ advisory panel (2024-). He is also a founding member of the Association of ERC Grantees (AERG) and serves on the Scientific Advisory Board of Life Science Center at Vilnius University. Academia Europaea Member (2018-) EMBO Member (2018-) Leadership Academy for Poland (2018) His research spans structural biology, RNA modification, computational biology, and molecular evolution. He has pioneered computational methods like ModeRNA, SimRNA, and ClaRNA for RNA structure prediction and analysis, and developed databases like MODOMICS for RNA modification pathways. His work has applications in understanding RNA function and drug design targeting RNA-processing enzymes. The 15 most recent publications focus on RNA structural modeling (e.g., ModeRNA, ClaRNA, SupeRNAlign), RNA-ligand interactions (LigandRNA), and RNA modification biology (MODOMICS database). These works bridge computational methods with experimental validation in RNA enzymology and structure-function relationships. Scientific Awards: ERC Starting Grant (2010), EMBO Member (2018), Crystal Brussels Sprout (2016), Prime Minister’s Award (2014), Knight’s Cross of Polonia Restituta (2014) Grants & Leadership: Founded RNA bioinformatics infrastructure at IIMCB, led EU science policy advisory groups, and organized international research competitions (RNA Puzzles)
Montserrat Anguera, Ph.D. is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania's School of Veterinary Medicine. Her research focuses on epigenetic mechanisms of gene regulation underlying sex differences in development and disease, with particular emphasis on X-chromosome inactivation (XCI) and its implications for female-biased autoimmune disorders. Dr. Anguera investigates how gene expression from the X-chromosome is regulated to ensure dosage compensation between males and females, and how these mechanisms become altered in diseases exhibiting sex-bias. Her laboratory has established novel epigenetic pathways involving the X-chromosome that impact human development, immune responses, and lymphocyte function. She employs advanced techniques including RNA/DNA fluorescence in situ hybridization, immunofluorescence, and allele-specific RNA sequencing to achieve single-cell resolution of epigenetic characteristics of the inactive X chromosome. Her research reveals a consistent focus on the intersection of X-chromosome biology and immunology, particularly regarding sex-biased autoimmune diseases like systemic lupus erythematosus. Key findings include the discovery that lymphocytes maintain X-chromosome inactivation differently than other somatic cells, with the inactive X exhibiting euchromatic features in female lymphocytes that may underlie female bias in autoimmune disorders. She coined the term 'dynamic XCI maintenance' to describe how T and B cells relocalize Xist RNA and heterochromatic marks to the inactive X chromosome following antigen-mediated stimulation. Dr. Anguera's laboratory includes postdocs Katherine Forsyth and Nikhil Jiwrajka, research specialist Zowie Searcy, graduate students Isabel Sierra and Natalie Toothacre, postdoctoral researcher Nuriban Valero-Pacheco, and PhD student Emma Welter. Together, they investigate epigenetic regulation of X-linked genes in development and disease contexts. She is an active member of multiple prestigious research institutes at Penn, including the Epigenetics Institute, Institute for Immunology, Center for Research on Reproduction & Women's Health, and Institute for Regenerative Medicine. Her work bridges epigenetics, immunology, and developmental biology, providing novel insights into mechanisms underlying female-biased autoimmune disorders.
Chen Ran, PhD, is an Assistant Professor in the Department of Neuroscience at Scripps Research in San Diego. His laboratory focuses on understanding how the brain processes internal sensory signals from visceral organs, such as hunger, satiety, nausea, and visceral pain. Using advanced techniques like in vivo two-photon calcium imaging, optogenetics, and circuit tracing, his team maps the functional architecture of brainstem circuits responsible for interoceptive processing. Key contributions include the discovery of a 'visceral homunculus' in the brainstem and the development of novel calcium indicators for high-resolution neuronal activity tracking. Education : PhD in Biology, Stanford University (2017) Bachelor of Science in Biology, Peking University (2011) Research Interests : Dr. Ran’s work integrates experimental and analytical approaches to decode how visceral stimuli are transduced into conscious sensations. Current projects investigate the coding logic of mechanical, chemical, and thermal signals from internal organs, with implications for developing therapies for obesity, diabetes, visceral pain, and eating disorders. The lab employs cutting-edge tools to visualize and manipulate neural circuits in awake behaving mice, linking circuit-level activity to physiological states. Awards & Honors : NARSAD Young Investigator Award (2022) NIH K01 Career Development Award (2023) Simons Collaboration on the Global Brain Award (2022) Harvard Brain Science Initiative Award (2021) Grants & Funding : Supported by NIH, Simons Foundation, and private philanthropy, his research bridges basic science and translational medicine. Current grants focus on brainstem circuit mapping and developing therapeutic targets for interoceptive disorders. Labs & Affiliations : Dr. Ran leads an interdisciplinary team at Scripps Research’s Neuroscience Department, collaborating with engineers, geneticists, and clinicians to advance interoceptive neuroscience.
Prof. Jürgen Rühe is a Full Professor of Chemistry and Physics of Interfaces at the Institute of Microsystems Technology, Albert Ludwigs University of Freiburg, within the Faculty of Engineering. He serves as Deputy Coordinator of Research Area C and Principal Investigator for Research Areas A, B, C, and D. His expertise spans polymers at interfaces, metamaterials, biomedical surfaces, and self-healing materials. He leads the Cluster of Excellence liv MatS, focusing on adaptive and energy-autonomous materials systems. Education: Not explicitly stated in text. His research emphasizes programmable materials, 4D printing, and bioinspired design, with projects funded by the German Research Foundation (DFG). Notable contributions include anti-fog coatings, magnetic microactuators for cell stimulation, and hygromorphic materials for adaptive architecture. He supervises doctoral and postdoctoral researchers, advancing fields like tribology and surface functionalization. Key scientific achievements include developing C,H-insertion cross-linking (CHic) for durable polymer networks and exploring smart materials for biomedical and environmental applications. His work bridges fundamental polymer chemistry with practical applications in energy, healthcare, and sustainable architecture. He advises over ten doctoral students and collaborates with industry partners. His lab, part of the Institute of Microsystems Technology, focuses on micro- and nanostructuring, with projects funded by the Cluster of Excellence.
Gabriela V. Cohen Freue is an Associate Professor in the Department of Statistics at the University of British Columbia (UBC), Vancouver Campus, and holds a Canada Research Chair (CRC Tier 2). She leads an interdisciplinary research program focusing on developing robust statistical methodologies for analyzing high-dimensional data in genomics and proteomics, with applications in medical sciences. Her work addresses challenges such as outliers, collinearity, and measurement errors, with applications in biomarker discovery for diseases like multiple sclerosis, cardiovascular disorders, and asthma. Her academic journey includes collaborations across disciplines, including with the BC Cancer Agency, PROOF Centre of Excellence, and iCAPTURE. She has pioneered methods like the Penalized Elastic Net S-Estimator (PENSE) and contributed to proteomic data analysis tools such as the Protein Group Code Algorithm (PGCA). She also co-developed the MDQC quality control method for microarrays. Research interests include robust regression, biomarker development, and statistical methods for big data. Her team includes postdocs, PhD, and MSc students, with a focus on training in both statistical rigor and interdisciplinary collaboration. Notable grants include a CANSSI Collaborative Research Team Project (CRT) award for robust causal inference and prediction modeling. Teaching responsibilities span statistical consulting, high-dimensional biological data analysis, and generalized linear models. She emphasizes active learning and real-world problem-solving in her courses. Her lab’s work is supported by grants from the Data Science Institute (DSI) and collaborations with institutions like the PROOF Centre. Alumni of her group hold positions in academia (e.g., George Mason University) and industry (e.g., Merck, BC Cancer Research Centre).
Andrew B. Bocarsly is a Professor of Chemistry at Princeton University, affiliated with the Department of Chemistry within the Faculty of Arts and Sciences. His research focuses on physical inorganic chemistry, catalysis, materials science, and CO₂ conversion. He leads the Bocarsly Lab, which explores electrochemical and photochemical methods to convert CO₂ into fuels and valuable chemicals, emphasizing heterogeneous catalysts and novel materials like cyanogels. His work intersects with sustainability and energy applications, supported by collaborations with institutions like the Andlinger Center for Energy and the Environment. Research Interests: - Development of catalysts for CO₂ reduction to multi-carbon species - Electrocatalytic and photocatalytic mechanisms using transition metal complexes - Low-temperature synthesis of alloys and semiconductors via cyanogel systems - Design of photoelectrochemical systems for solar energy conversion Recent trends in his publications highlight advancements in catalyst design (e.g., Ni-enhanced oxides, manganese complexes), CO₂-to-CO/1-butanol conversion, and semiconductor materials for hydrogen evolution. His lab actively mentors students, with notable graduates like Andersen Dimon and Rebecca Evans. Collaborations extend to Princeton’s Materials Institute and the Electrochemical Society. Labs/Teams: The Bocarsly Lab operates in Frick Chemistry Laboratory, emphasizing interdisciplinary approaches to energy sustainability. Recent activities include hosting the 19th International Conference on Carbon Dioxide Utilization (2022) and fostering undergraduate and graduate research programs.
